As of Jan 13
| +0.11 / +0.72%|
The 8 analysts offering 12-month price forecasts for PTC Therapeutics Inc have a median target of 15.00, with a high estimate of 25.00 and a low estimate of 10.00. The median estimate represents a -3.04% decrease from the last price of 15.47.
The current consensus among 9 polled investment analysts is to Hold stock in PTC Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.